MaxWell Biosystems AG
Advanced cell-imaging platform for drug development.
MaxWell Biosystems is a global leader providing advanced high-resolution functional cell imaging platforms to facilitate detailed investigation of cells. MaxOne (single-well) and MaxTwo (multi-well) allow stimulation and recording of every active cell on a dish at unprecedented spatio-temporal resolution. These instruments advance and accelerate drug discovery and basic neurosciences.
Every cell has a story to tell. MaxWell Biosystems aims to equip everyone with tools to easily observe, track, and discover cells' functionality, health, maturity, and response to compounds.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
01.07.2025
Maxwell Biosystems and 8inks on an international growth course (startupticker.ch)
11.03.2024
Promising new tool for uncovering key characteristics of neurodegenerative diseases (startupticker.ch)
27.10.2023
Credit Suisse investors and TOP 100 Startups connect over a table tennis tournament in Zurich (venturelab.swiss)
10.12.2021
Loan guarantees for five startups (startupticker.ch)
17.12.2020
MaxWell Biosystems obtains CHF 4 million in Series A financing round (startupticker.ch)
Last Tweets
No Jobs
Videos
Company Video
TOP 100 Swiss Startup Award
The TOP 100 Swiss Startup Ranking features the 100 most promising startups that are not older than five years and are selected by a jury of early-stage investors.
Venture Kick
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
Venture Leaders Life Sciences
The venture leaders - the members of the Swiss national startup team- have a clear-cut goal. They envision themselves as global players and want to take the first step to their global expansion. The ten-day business development program is specifically structured to help them achieve this goal.
MaxWell Biosystems AG
Advanced cell-imaging platform for drug development.
Website:
www.mxwbio.com/
Headquarter:
Zurich
Foundation Date:
September 2016
Technology:
- Biotech
Sectors:
- Biotech
- Electronics
- Drug development platforms
- Drug discovery
- Micro technologies
- Sensors
- Semiconductors
- Neurology
- Screening
Support received
